Will RVTY Q3 Earnings Reflect Segmental Strength Amid Rising Demand?Zacks Investment Research • 10/23/25
Revvity (RVTY) Q3 Earnings Preview: What You Should Know Beyond the Headline EstimatesZacks Investment Research • 10/22/25
Analysts Estimate Revvity (RVTY) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 10/20/25
RVTY Collaborates With Sanofi for Early Detection of Type 1 DiabetesZacks Investment Research • 10/09/25
Revvity Announces Program to Revolutionize the Early Detection of Type 1 DiabetesBusiness Wire • 10/02/25
Revvity Unveils New AI Software Offering to Transform Preclinical Imaging AnalysisBusiness Wire • 09/29/25
Revvity and Profluent Collaborate to Launch AI-Enhanced Adenine Deaminase Pin-point Base Editing SystemsBusiness Wire • 09/22/25
Revvity, Inc. (RVTY) Presents At Baird 2025 Global Healthcare Conference (Transcript)Seeking Alpha • 09/09/25
Revvity, Inc. (RVTY) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 TranscriptSeeking Alpha • 09/03/25
Revvity Launches Innovative Reagent Technology to Accelerate Development of Next-Generation Targeted TherapeuticsBusiness Wire • 08/06/25
Revvity (RVTY) Q2 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • 07/28/25
ATAI Life Sciences, Revvity And Other Big Stocks Moving Lower In Monday's Pre-Market SessionBenzinga • 07/28/25